MIDD Webinar Series | Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis perspectives on this Model Informed Drug Development application
Includes a Live Web Event on 03/19/2025 at 12:00 PM (EDT)
-
You must log in to register
- Member - Free!
Already registered?
Log in now.
The MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.